tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market
CTNM
Contineum Therapeutics, Inc. Class A
RESEARCH TOOLSreports

Contineum Therapeutics, Inc. Class A (CTNM) Financial Statements

Compare
212 Followers

Contineum Therapeutics, Inc. Class A Financial Overview

Contineum Therapeutics, Inc. Class A's market cap is currently $517.02M. The company's EPS TTM is $-0.49; its P/E ratio is -5.28; Contineum Therapeutics, Inc. Class A is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 50.00M$ 0.00$ 0.00
Gross Profit$ -323.00K$ -258.00K$ 50.00M$ -329.00K$ 0.00
Operating Income$ -68.06M$ -50.89M$ -16.08M$ -22.72M$ -28.65M
EBITDA$ -68.06M$ -42.00M$ 23.57M$ -23.54M$ -28.34M
Net Income$ -59.98M$ -42.26M$ 22.72M$ -24.25M$ -29.00M
Balance Sheet
Cash & Short-Term Investments$ 262.90M$ 204.76M$ 125.19M$ 47.24M$ 69.00M
Total Assets$ 276.64M$ 212.85M$ 130.39M$ 50.64M$ 70.52M
Total Debt$ 8.25M$ 6.26M$ 193.19M$ 5.85M$ 4.91M
Net Debt$ -67.35M$ -15.68M$ 177.67M$ 280.00K$ 279.00K
Total Liabilities$ 15.65M$ 14.78M$ 198.32M$ 11.37M$ 8.93M
Stockholders' Equity$ 260.99M$ 198.07M$ -67.94M$ 39.27M$ 61.59M
Cash Flow
Free Cash Flow$ -55.54M$ -33.36M$ 18.93M$ -20.24M$ -26.43M
Operating Cash Flow$ -55.31M$ -32.84M$ 19.35M$ -20.12M$ -26.27M
Investing Cash Flow$ -3.71M$ -69.74M$ -65.57M$ 22.30M$ -64.97M
Financing Cash Flow$ 112.69M$ 109.00M$ 56.18M$ -1.24M$ 79.84M
Currency in USD

Contineum Therapeutics, Inc. Class A Earnings and Revenue History

Income Statement >

Contineum Therapeutics, Inc. Class A Debt to Assets

Balance Sheet >

Contineum Therapeutics, Inc. Class A Cash Flow

Cash Flow >

Contineum Therapeutics, Inc. Class A Forecast EPS vs Actual EPS

Earnings >